YKL-40 is elevated in cerebrospinal fluid from patients with purulent meningitis

Research output: Contribution to journalJournal articleResearchpeer-review

Standard

YKL-40 is elevated in cerebrospinal fluid from patients with purulent meningitis. / Ostergaard, C; Johansen, JS; Benfield, Thomas; price, PA; Lundgren, Jens Dilling.

In: Clinical and Vaccine Immunology, Vol. 9, No. 3, 2002, p. 598-604.

Research output: Contribution to journalJournal articleResearchpeer-review

Harvard

Ostergaard, C, Johansen, JS, Benfield, T, price, PA & Lundgren, JD 2002, 'YKL-40 is elevated in cerebrospinal fluid from patients with purulent meningitis', Clinical and Vaccine Immunology, vol. 9, no. 3, pp. 598-604. https://doi.org/10.1128/CDLI.9.3.598-604.2002

APA

Ostergaard, C., Johansen, JS., Benfield, T., price, PA., & Lundgren, J. D. (2002). YKL-40 is elevated in cerebrospinal fluid from patients with purulent meningitis. Clinical and Vaccine Immunology, 9(3), 598-604. https://doi.org/10.1128/CDLI.9.3.598-604.2002

Vancouver

Ostergaard C, Johansen JS, Benfield T, price PA, Lundgren JD. YKL-40 is elevated in cerebrospinal fluid from patients with purulent meningitis. Clinical and Vaccine Immunology. 2002;9(3):598-604. https://doi.org/10.1128/CDLI.9.3.598-604.2002

Author

Ostergaard, C ; Johansen, JS ; Benfield, Thomas ; price, PA ; Lundgren, Jens Dilling. / YKL-40 is elevated in cerebrospinal fluid from patients with purulent meningitis. In: Clinical and Vaccine Immunology. 2002 ; Vol. 9, No. 3. pp. 598-604.

Bibtex

@article{9b49fbe5e4024af4905cb156f013be05,
title = "YKL-40 is elevated in cerebrospinal fluid from patients with purulent meningitis",
abstract = "YKL-40, a member of the family 18 glycosyl hydrolases, is secreted by activated neutrophils and macrophages. It is a growth factor for connective tissue cells and a potent migration factor for endothelial cells and may function in inflammation and tissue remodeling. YKL-40 was determined in 134 cerebrospinal fluid (CSF) samples taken on admission from patients suspected of having meningitis (48 with purulent meningitis, 49 with lymphocytic meningitis, 5 with encephalitis, and 32 without evidence of meningitis). YKL-40 levels in CSF were significantly higher in patients with purulent meningitis (median, 663 microg/liter [range, 20 to 8,960]) and encephalitis (5,430 microg/liter [620 to 11,600]) than in patients with lymphocytic meningitis (137 microg/liter [41 to 1,865]) or patients without meningitis (167 microg/liter [24 to 630]) (Kruskal-Wallis and Dunn multiple comparison tests, P < 0.001). CSF YKL-40 levels were also determined for 26 patients with purulent meningitis having a repuncture, and patients who died (n = 5) had significantly higher YKL-40 levels than patients who survived (n = 21) (2,100 microg/liter [1,160 to 7,050] versus 885 microg/liter [192 to 15,400], respectively; Mann-Whitney test, P = 0.018). YKL-40 was most likely locally produced, since patients with infections of the central nervous system had CSF YKL-40 levels that were at least 10-fold higher than the corresponding levels in serum (2,033 microg/liter [470 to 11,600] versus 80 microg/liter [19 to 195]). The CSF neopterin level was the biochemical parameter in CSF and blood that correlated best with CSF YKL-40 levels, indicating that YKL-40 may be produced by activated macrophages within the central nervous system. In conclusion, high levels of YKL-40 in CSF are found in patients with purulent meningitis.",
author = "C Ostergaard and JS Johansen and Thomas Benfield and PA price and Lundgren, {Jens Dilling}",
year = "2002",
doi = "http://dx.doi.org/10.1128/CDLI.9.3.598-604.2002",
language = "English",
volume = "9",
pages = "598--604",
journal = "Clinical and Diagnostic Laboratory Immunology",
issn = "1556-6811",
publisher = "American Society for Microbiology",
number = "3",

}

RIS

TY - JOUR

T1 - YKL-40 is elevated in cerebrospinal fluid from patients with purulent meningitis

AU - Ostergaard, C

AU - Johansen, JS

AU - Benfield, Thomas

AU - price, PA

AU - Lundgren, Jens Dilling

PY - 2002

Y1 - 2002

N2 - YKL-40, a member of the family 18 glycosyl hydrolases, is secreted by activated neutrophils and macrophages. It is a growth factor for connective tissue cells and a potent migration factor for endothelial cells and may function in inflammation and tissue remodeling. YKL-40 was determined in 134 cerebrospinal fluid (CSF) samples taken on admission from patients suspected of having meningitis (48 with purulent meningitis, 49 with lymphocytic meningitis, 5 with encephalitis, and 32 without evidence of meningitis). YKL-40 levels in CSF were significantly higher in patients with purulent meningitis (median, 663 microg/liter [range, 20 to 8,960]) and encephalitis (5,430 microg/liter [620 to 11,600]) than in patients with lymphocytic meningitis (137 microg/liter [41 to 1,865]) or patients without meningitis (167 microg/liter [24 to 630]) (Kruskal-Wallis and Dunn multiple comparison tests, P < 0.001). CSF YKL-40 levels were also determined for 26 patients with purulent meningitis having a repuncture, and patients who died (n = 5) had significantly higher YKL-40 levels than patients who survived (n = 21) (2,100 microg/liter [1,160 to 7,050] versus 885 microg/liter [192 to 15,400], respectively; Mann-Whitney test, P = 0.018). YKL-40 was most likely locally produced, since patients with infections of the central nervous system had CSF YKL-40 levels that were at least 10-fold higher than the corresponding levels in serum (2,033 microg/liter [470 to 11,600] versus 80 microg/liter [19 to 195]). The CSF neopterin level was the biochemical parameter in CSF and blood that correlated best with CSF YKL-40 levels, indicating that YKL-40 may be produced by activated macrophages within the central nervous system. In conclusion, high levels of YKL-40 in CSF are found in patients with purulent meningitis.

AB - YKL-40, a member of the family 18 glycosyl hydrolases, is secreted by activated neutrophils and macrophages. It is a growth factor for connective tissue cells and a potent migration factor for endothelial cells and may function in inflammation and tissue remodeling. YKL-40 was determined in 134 cerebrospinal fluid (CSF) samples taken on admission from patients suspected of having meningitis (48 with purulent meningitis, 49 with lymphocytic meningitis, 5 with encephalitis, and 32 without evidence of meningitis). YKL-40 levels in CSF were significantly higher in patients with purulent meningitis (median, 663 microg/liter [range, 20 to 8,960]) and encephalitis (5,430 microg/liter [620 to 11,600]) than in patients with lymphocytic meningitis (137 microg/liter [41 to 1,865]) or patients without meningitis (167 microg/liter [24 to 630]) (Kruskal-Wallis and Dunn multiple comparison tests, P < 0.001). CSF YKL-40 levels were also determined for 26 patients with purulent meningitis having a repuncture, and patients who died (n = 5) had significantly higher YKL-40 levels than patients who survived (n = 21) (2,100 microg/liter [1,160 to 7,050] versus 885 microg/liter [192 to 15,400], respectively; Mann-Whitney test, P = 0.018). YKL-40 was most likely locally produced, since patients with infections of the central nervous system had CSF YKL-40 levels that were at least 10-fold higher than the corresponding levels in serum (2,033 microg/liter [470 to 11,600] versus 80 microg/liter [19 to 195]). The CSF neopterin level was the biochemical parameter in CSF and blood that correlated best with CSF YKL-40 levels, indicating that YKL-40 may be produced by activated macrophages within the central nervous system. In conclusion, high levels of YKL-40 in CSF are found in patients with purulent meningitis.

U2 - http://dx.doi.org/10.1128/CDLI.9.3.598-604.2002

DO - http://dx.doi.org/10.1128/CDLI.9.3.598-604.2002

M3 - Journal article

VL - 9

SP - 598

EP - 604

JO - Clinical and Diagnostic Laboratory Immunology

JF - Clinical and Diagnostic Laboratory Immunology

SN - 1556-6811

IS - 3

ER -

ID: 40213429